The commonest site of pressure sore is :
Among the following sites, which is the most common location for development of pressure sores in debilitated patients?
Consider following statements in respect of parenteral nutrition : 1. indicated in patients when enteral nutrition cannot be given 2. parenteral route is a better choice than enteral route 3. abnormalities of liver functions can occur on prolonged use 4. hyperglycemia is common Which of the above statements are correct ?
What is the most frequent complication of Total Parenteral Nutrition (TPN)?
During the discharge of a COVID patient treated with steroids and remdesivir, which of the following will you inform him about? 1. Repeat RT-PCR after 7 days of discharge 2. Watch for the persistence of Anosmia 3. Watch for headache and nasal discharge 4. Monitor glucose levels 5. Watch for Sinusitis symptoms
Which of the following causes the majority of UTIs in hospitalized patients?
A 71-year-old man develops dysphagia for both solids and liquids and weight loss of 60 lb over the past 6 months. He undergoes endoscopy, demonstrating a distal esophageal lesion, and biopsies are consistent with squamous cell carcinoma. He is scheduled for neoadjuvant chemoradiation followed by an esophagectomy. Preoperatively he is started on total parenteral nutrition, given his severe malnutrition reflected by an albumin of less than 1. Which of the following is most likely to be a concern initially in starting total parenteral nutrition in this patient?
Which of the following is a primary component of IV hyperalimentation?
An elderly male admitted for pneumonia presents with diarrhea and gripping abdominal pain five days after discharge from the hospital. Which drug is likely to benefit him?
Most common type of shock in emergency room is
Explanation: ***Heel*** - The **heel** is a common site for pressure sore development, especially in bedridden or immobile patients, due to sustained pressure on the bony prominence. - While less common as the *most* common site compared to the sacrum, it is still very frequently affected and can be equally severe. *Sacrum* - The **sacrum** is the *most common site* for pressure ulcers, particularly in individuals who are bed-bound or spend prolonged periods in a supine position. - This area experiences high pressure when lying on the back due to the body's weight pressing down on the bony prominence of the sacrum [1]. *Ischium* - The **ischial tuberosities** are common sites for pressure sores in individuals who are wheelchair-bound or spend extended periods in a seated position. - Pressure on this area is particularly high when sitting, making it vulnerable to tissue damage. *Occiput* - The **occiput** (back of the head) is a common site for pressure sores in infants, critically ill patients, or individuals who are supine for extended periods and unable to reposition their heads. - This is due to sustained pressure on the bony prominence of the skull against the mattress or support surface.
Explanation: Heel - The heels are a common location due to the localized pressure, especially in supine or chair-bound individuals, and are a high-risk area for developing pressure ulcers because they often bear a significant portion of body weight. [1] - The bone prominence and lack of subcutaneous fat make the skin over the heel particularly vulnerable to ischemia and tissue damage from sustained pressure. [1] Greater trochanter - The greater trochanter is a common site for pressure sore development, especially in individuals positioned in a lateral recumbent position. - However, it typically ranks second or third after the sacrum and heels in overall incidence for most debilitated patients. Ischium - The ischium is a high-risk area for pressure sores, particularly in patients who spend prolonged periods sitting. - While significant in seated patients, it is not the most common site generally across all debilitated patients and various positions. Occiput - The occiput is a risk area for pressure sores, especially in patients who are critically ill, intubated, or lying supine for extended periods. - While it is a significant concern for certain patient populations, it is generally less common than the heels or sacrum for pressure ulcer development in the broad category of debilitated patients.
Explanation: ***1, 3 and 4 only*** - **Parenteral nutrition (PN)** is used when the gastrointestinal tract is non-functional or inaccessible, making **enteral nutrition (EN)** impossible or inadequate. - **Hyperglycemia** is a common complication due to the high glucose content in PN solutions, and **liver function abnormalities** (e.g., cholestasis, steatosis) can develop with prolonged use. *2, 3 and 4 only* - This option incorrectly states that the parenteral route is better than the enteral route. **Enteral nutrition** is generally preferred due to being more physiological, safer, and less expensive [1]. - While hyperglycemia and liver dysfunction are correct complications, the assertion about the superiority of the parenteral route is false. *1, 2 and 3 only* - This option incorrectly claims that **parenteral nutrition** is a better choice than the enteral route (statement 2). **Enteral nutrition** is always the preferred route if the gut works [1]. - It also omits **hyperglycemia**, which is a frequent and significant complication of parenteral nutrition. *1, 2, 3 and 4* - This option incorrectly includes statement 2, which suggests the parenteral route is superior to the enteral route. **Enteral nutrition** is always preferred when feasible [1]. - While statements 1, 3, and 4 are correct, the inclusion of statement 2 makes this option incorrect.
Explanation: ***Hyperglycemia*** - **Hyperglycemia** is the most common metabolic complication of TPN due to the high dextrose content, especially in patients with pre-existing glucose intolerance or stress. - Close monitoring of blood glucose and insulin administration are often necessary to manage this complication. *Rebound hyperglycemia* - **Rebound hyperglycemia** typically refers to a surge in blood glucose levels following a period of hypoglycemia, or in response to a sudden cessation of insulin, neither of which is the most frequent primary complication of TPN initiation. - While TPN can cause hyperglycemia, the term "rebound hyperglycemia" is not the most accurate description for the initial and most frequent TPN-associated glucose abnormality. *Hypoglycemia* - **Hypoglycemia** is less common during continuous TPN infusion but can occur if TPN is abruptly discontinued, or if excessive insulin is administered. - It is not the most frequent complication observed during steady-state TPN administration. *Hypertriglyceridemia* - **Hypertriglyceridemia** can occur with TPN, particularly with excessive lipid emulsion administration or in patients with impaired lipid metabolism. - Although a potential complication, it is not as frequent as hyperglycemia.
Explanation: **3, 4, and 5** - For patients treated with **steroids**, it is crucial to monitor **glucose levels** due to the potential for steroid-induced hyperglycemia [1]. - Symptoms like **headache** and **nasal discharge** (and by extension **sinusitis symptoms**) could indicate conditions like **mucormycosis**, a serious fungal infection seen in immunocompromised COVID-19 patients, especially those having received steroids. *1, 3, and 4* - A **repeat RT-PCR after 7 days** of discharge is generally not recommended as per current guidelines, as viral shedding can persist without infectivity. - While monitoring for headache, nasal discharge, and glucose levels is appropriate, omitting the direct vigilance for **sinusitis symptoms** is less comprehensive. *2, 3, and 4* - While **anosmia** (loss of smell) can persist post-COVID, it is primarily a lingering symptom of the infection itself and typically resolves spontaneously, not usually requiring specific discharge instructions for monitoring its persistence to prevent complications. - The focus should be on new or worsening symptoms that might indicate post-COVID complications or secondary infections. *1, 2, 3, 4, and 5* - Including **repeat RT-PCR** and solely "watch for the persistence of Anosmia" without emphasizing resolution or specific actions makes this option less pertinent for discharge advice. - The priority for discharge instructions should be preventable complications and warning signs of serious conditions.
Explanation: ***Invasive procedures*** - The use of **urinary catheters** or other urological interventions significantly increases the risk of UTIs in hospitalized patients by providing a direct route for bacteria to enter the bladder [1]. - Catheter-associated UTIs (**CAUTIs**) are the most common type of healthcare-associated infection and are predominantly linked to invasive procedures [1]. *Inadequate perineal care* - While poor perineal hygiene can contribute to UTIs, it is typically a less significant factor than invasive procedures in the hospitalized setting, where **catheterization** is a major risk. - Good perineal care is important but cannot fully mitigate the risk introduced by **indwelling catheters**. *Lack of fluid intake* - Insufficient fluid intake can lead to concentrated urine, which may increase the risk of UTI in general, but it is not the primary cause of UTIs in **hospitalized patients**. [2] - **Urine stasis** due to mechanical obstruction or poor bladder emptying (often associated with catheters) is a greater factor than simply reduced fluid intake. *Immunosuppression* - Immunosuppression can increase susceptibility to infections, including UTIs, but it is not the leading cause of UTIs in most hospitalized patients. - The **direct introduction of bacteria** during invasive procedures more commonly bypasses the body's natural defenses, even in immunocompetent individuals.
Explanation: ***Hypophosphatemia*** * This patient with severe malnutrition (albumin <1, 60lb weight loss) is at high risk for **refeeding syndrome** when TPN is initiated [1]. * Upon refeeding, **insulin release** causes intracellular shifts of electrolytes, particularly phosphate, leading to severe hypophosphatemia [1]. * *Hypoglycemia* * TPN contains dextrose, which typically causes **hyperglycemia**, not hypoglycemia, especially given its continuous infusion. * Hypoglycemia would be more likely if TPN was abruptly discontinued, causing a rapid drop in glucose levels as basal insulin continues to be secreted. * *Hyperkalemia* * Refeeding syndrome typically causes a rapid **intracellular shift of potassium**, leading to **hypokalemia**, not hyperkalemia [1]. * Hyperkalemia would be a concern in patients with renal insufficiency or those receiving potassium-sparing diuretics. * *Hypermagnesemia* * Similar to potassium and phosphate, refeeding syndrome usually causes an **intracellular shift of magnesium**, leading to **hypomagnesemia** [1]. * Hypermagnesemia is rare and typically seen in patients with severe renal failure or excessive exogenous magnesium intake (e.g., antacids).
Explanation: ***Dextrose*** - **Dextrose** (glucose) is a primary component of IV hyperalimentation (TPN) because it provides the main source of **carbohydrates** and **calories**, essential for energy [2], [4]. - It helps meet the body's metabolic demands and prevents **catabolism** of muscle protein for energy [1], [5]. *Amino acids* - **Amino acids** are crucial components of TPN, supplying the building blocks for **protein synthesis** and tissue repair [3]. - While essential, they are not the primary caloric source; that role is primarily filled by carbohydrates (dextrose) and fats. *Fats* - **Fats** (lipid emulsions) are a vital part of TPN, providing a concentrated source of **calories** and **essential fatty acids**. - However, dextrose typically constitutes the largest proportion of total calories in TPN formulations to ensure adequate glucose supply. *Hypertonic saline* - **Hypertonic saline** is used to treat conditions like severe **hyponatremia** or cerebral edema, not as a nutritional component of hyperalimentation. - Administering it as a primary component of TPN would disrupt electrolyte balance and could lead to severe adverse effects. *LMW dextran* - **Low molecular weight (LMW) dextran** is a plasma expander used to prevent **thrombosis** and improve **microcirculation**, often in surgical settings. - It has no nutritional value and is not a component of IV hyperalimentation.
Explanation: **Metronidazole** - The symptoms of diarrhea and gripping abdominal pain five days post-discharge, especially after a hospital stay for pneumonia, strongly suggest **Clostridioides difficile infection (CDI)**, which is commonly associated with antibiotic use [1]. - **Metronidazole** is a first-line antibiotic used to treat mild to moderate CDI. *Levofloxacin* - **Levofloxacin** is a fluoroquinolone antibiotic and a common cause of **Clostridioides difficile infection** rather than a treatment for it [2]. - Using levofloxacin would likely worsen or perpetuate the underlying infection. *Imodium* - **Imodium (loperamide)** is an over-the-counter anti-diarrheal medication that works by slowing bowel movements. - It is generally **contraindicated** in infectious diarrhea, especially CDI, as it can delay the clearance of toxins and potentially lead to **toxic megacolon** [1]. *Diphenoxylate* - **Diphenoxylate** (often combined with atropine) is an opioid-receptor agonist used to slow intestinal motility and treat diarrhea. - Similar to loperamide, it can be harmful in cases of **infectious diarrhea** like CDI, as it may prolong exposure to toxins and worsen the condition.
Explanation: ***Hypovolaemic*** - **Hypovolemic shock** is the most frequent type of shock encountered in emergency rooms due to its association with a wide range of common conditions, such as **hemorrhage** (trauma, gastrointestinal bleeding) and severe dehydration. - It results from a significant **loss of circulating blood volume**, leading to inadequate tissue perfusion [2]. *Obstructive* - **Obstructive shock** occurs when there is a physical obstruction to blood flow, such as in **pulmonary embolism** [1] or **cardiac tamponade** [3]. - While serious, these conditions are less common overall in the emergency setting compared to causes of hypovolemia. *Cardiogenic* - **Cardiogenic shock** is caused by the heart's inability to pump sufficient blood, typically due to **myocardial infarction** [3] or severe heart failure. - Although life-threatening, it is less common than hypovolemic shock as a primary presenting etiology in the emergency department. *Neurogenic* - **Neurogenic shock** is a distributive shock caused by a severe injury to the **central nervous system**, leading to loss of sympathetic tone and widespread vasodilation. - While it can be seen in severe trauma, it is a specific and less common form of shock compared to hypovolemia.
Explanation: ***Isotonic*** - Ringer's lactate is **isotonic** because its osmolality (approximately $ ext{273 mOsmol/L}$) is similar to that of human plasma ($ ext{275-295 mOsmol/L}$), making it suitable for intravenous fluid replacement [1]. - This characteristic prevents significant shifts of fluid in or out of cells, reducing the risk of **cellular edema** or **dehydration** [1]. *Provides bicarbonate precursors to help in metabolic acidosis.* - While Ringer's lactate contains **lactate**, which is metabolized in the liver to **bicarbonate**, this effect is considered a secondary benefit rather than its most clinically significant characteristic [2]. - The primary clinical utility of Ringer's lactate is its ability to effectively restore **intravascular volume** due to its isotonic nature [2]. *Crystalloid solution.* - Ringer's lactate is indeed a **crystalloid solution**, meaning it contains small molecules that can freely cross semipermeable membranes [1]. - However, being a crystalloid is a classification, while its **isotonicity** is a more direct and clinically significant characteristic regarding its physiological impact and primary use. *Contains potassium in a concentration lower than serum potassium.* - Ringer's lactate contains **potassium** (4 mEq/L), but this concentration is lower than typical serum potassium levels ($ ext{3.5-5.0 mEq/L}$) [2]. - This characteristic is important for fluid balance but not its most defining or clinically significant feature compared to its overall isotonicity.
Explanation: ***Epinephrine .5 ml of 1:1000 IM*** - **Epinephrine** is the **first-line treatment** for anaphylaxis due to its alpha-1 agonist effects (vasoconstriction, which increases blood pressure) and beta-2 agonist effects (bronchodilation, which improves breathing). [1] - The recommended dose and concentration for intramuscular administration in adults is **0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) IM**, repeated every 5-15 minutes as needed. *Atropine 3 mg intravenously* - **Atropine** is an anticholinergic medication used to treat **bradycardia** or organophosphate poisoning, not anaphylaxis. [4] - It does not address the widespread vasaodilation or bronchoconstriction seen in anaphylactic shock. *Adenosine 12 mg intravenously* - **Adenosine** is an antiarrhythmic drug primarily used to convert **supraventricular tachycardia (SVT)** to normal sinus rhythm. [3] - It has no role in the management of anaphylactic shock. *Epinephrine 1 ml of 1:10000 intravenously* - While epinephrine is the correct drug, **intravenous administration** of epinephrine 1:10,000 is typically reserved for **cardiac arrest** [2] or in cases of severe, refractory anaphylaxis under expert care, and carries a higher risk of adverse effects. - The initial and preferred route for anaphylaxis is **intramuscular**, as it provides rapid absorption with lower risks compared to IM administration.
Explanation: ***Leucocyte reduction*** - **Febrile non-hemolytic transfusion reactions (FNHTRs)** are primarily caused by cytokines released from donor leukocytes during storage or by recipient antibodies targeting donor leukocytes [1]. - **Leukocyte reduction** removes these donor white blood cells, thereby significantly decreasing the risk of FNHTRs. *Washing* - **Washing** removes plasma proteins and antibodies, which is useful for preventing allergic reactions or anaphylaxis in patients with IgA deficiency, but it is not the primary method for preventing FNHTRs. - While it can remove some cytokines, its main indication is different from preventing leukocyte-mediated reactions. *Irradiation* - **Irradiation** is performed to prevent **transfusion-associated graft-versus-host disease (TA-GVHD)** by inactivating donor lymphocytes, preserving their function but preventing their proliferation. - It does not primarily reduce the number of leukocytes or the associated cytokine release responsible for FNHTRs. *Glycerolization* - **Glycerolization** is a process used to cryopreserve **red blood cells** for long-term storage, often decades. - This process is essential for maintaining the viability of red blood cells in frozen storage but has no direct role in preventing FNHTRs.
Explanation: ***Metabolic alkalosis*** - **Citrate**, an anticoagulant in stored blood, is metabolized by the liver into **bicarbonate**, which can accumulate with massive transfusion. [2] - This bicarbonate excess leads to a rise in blood pH, causing **metabolic alkalosis**. [2] *Respiratory alkalosis* - This typically results from **hyperventilation**, leading to excessive CO2 exhalation. [1] - It is not a direct complication of the chemical constituents or physiological effects of massive blood transfusions. *Metabolic acidosis* - While sometimes seen in early phases due to reduced tissue perfusion or hypothermia in massive transfusion, the predominant and later complication (especially with adequately functioning liver) is metabolic alkalosis due to citrate metabolism. - **Lactic acidosis** can occur in shock or hypoperfusion states, but the buffering capacity and citrate metabolism often shift towards alkalosis. *Respiratory acidosis* - This results from **hypoventilation** or impaired CO2 removal, leading to CO2 retention in the blood. [1] - It is not directly caused by the components of a massive blood transfusion itself.
Explanation: ***Unequally dilated pupils*** - **Unequally dilated pupils** are not a component of the **qSOFA** score. This finding can be indicative of neurological issues such as increased **intracranial pressure** or **uncal herniation**, but not directly part of the sepsis screening tool [1]. - The qSOFA score focuses on easily obtainable clinical signs to rapidly identify patients at risk for poor outcomes from **sepsis**. *Respiratory rate >22/min* - A **respiratory rate greater than 22 breaths per minute** is one of the three criteria for the **qSOFA** score, indicating significant physiological stress. - This elevated respiratory rate suggests an increased work of breathing, often due to **metabolic acidosis** or **systemic inflammation** associated with sepsis. *Altered mental status* - **Altered mental status** (e.g., Glasgow Coma Scale score less than 15) is a core component of the **qSOFA** score [1]. - This sign reflects **cerebral hypoperfusion** or **encephalopathy** due to the systemic effects of sepsis [1]. *Systolic BP<100 mmHg* - A **systolic blood pressure less than 100 mmHg** is another key criterion of the **qSOFA** score. - This indicates **hypotension** and suggests inadequate tissue perfusion, a critical sign of **circulatory dysfunction** in sepsis [1].
Explanation: A **16-gauge (Grey)** cannula allows for a high flow rate, making it ideal for rapid fluid resuscitation in severely dehydrated patients [1]. This size is crucial for quickly restoring intravascular volume in cases of severe dehydration and diarrhea where large amounts of fluid are lost. [2] A **20-gauge (Pink)** cannula offers a moderate flow rate, suitable for routine intravenous fluid administration or medication delivery, but generally too slow for rapid resuscitation in severe dehydration. An **18-gauge (Green)** cannula provides a good flow rate, making it suitable for blood transfusions or moderate fluid resuscitation. A **22-gauge (Blue)** cannula has a slow flow rate, typically used for pediatric patients, elderly patients with fragile veins, or for maintaining venous access for medication administration.
Explanation: ***Depth of pressure is 2 to 3 cm*** - This option describes an **incorrect depth** for chest compressions in adult CPR. - The recommended compression depth for adults is approximately **5-6 cm (2 to 2.4 inches)** to ensure effective blood flow. *100/120 rate per minute* - This rate of **100 to 120 compressions per minute** is the correct and recommended pace for adult CPR, ensuring adequate blood circulation. - A faster or slower rate can compromise the effectiveness of chest compressions. *Compression to ventilation ratio is 30:2* - A **compression-to-ventilation ratio of 30:2** is the standard for adult CPR, particularly for a single rescuer. - This ratio optimizes both blood flow and oxygen delivery to the patient. *Allow complete recoil in between* - Allowing **complete chest recoil** after each compression is crucial for effective CPR. - This permits the heart to fully refill with blood, maximizing cardiac output with each subsequent compression.
Explanation: ***Central venous catheters are advantageous for long-term chemotherapy despite their infection risks.*** - **Central venous catheters (CVCs)** provide reliable long-term access for chemotherapy that may be infused continuously or given over many cycles, minimizing repeated **venipunctures**. [1] - Although CVCs carry a higher risk of **catheter-related bloodstream infections (CRBSIs)** and complications like **thrombosis**, the benefits for prolonged and vesicant chemotherapy often outweigh these risks [1]. *Peripheral lines are associated with lower infection risk and greater patient comfort, making them suitable for short-term use.* - While **peripheral intravenous (PIV) lines** do have a lower initial infection risk and can be more comfortable for *single, short-term infusions*, they are generally unsuitable for **long-term chemotherapy** or **vesicant drugs** [1]. - Their shorter lifespan and risk of **infiltration** and **phlebitis** with prolonged or irritating infusions make them impractical for extended treatment regimens. *Peripheral lines should be used when minimizing infection risk is a priority.* - Although PIVs have a lower infection risk than CVCs for *short-term, non-irritating infusions*, they are not practical for **long-term chemotherapy** and the risk of **repeated venipunctures** can itself introduce infection risk over time. - For vesicant chemotherapy, peripheral lines carry a significant risk of **extravasation**, leading to tissue damage, which outweighs the perceived advantage of lower infection risk in this context [1]. *Central venous catheters should be avoided due to their higher infection risk compared to peripheral lines.* - While CVCs do have an inherently greater risk of **CRBSIs** due to their invasive nature and direct access to central circulation, avoiding them entirely is not appropriate for patients requiring **long-term** or **irritating chemotherapy** [1]. - The benefits of consistent, reliable access, the ability to infuse **vesicants** safely, and avoidance of **repeated peripheral venipunctures** often make CVCs the preferred and medically necessary option despite their risks.
Explanation: ***Syndrome of inappropriate antidiuretic hormone secretion (SIADH)*** - **SIADH** is the most common cause of euvolemic hyponatremia in hospitalized patients [1]. - It results from excessive ADH release, leading to water retention, expanded extracellular fluid volume, and subsequent **dilutional hyponatremia** [2]. *Congestive heart failure* - Patients with **congestive heart failure** often develop hyponatremia due to increased ADH and activation of the renin-angiotensin-aldosterone system, leading to water retention [1]. - However, this is typically a **hypervolemic hyponatremia** and is less common overall than SIADH in the general hospitalized population [1]. *Cirrhosis* - **Cirrhosis** can cause hyponatremia, usually hypervolemic, due to impaired free water excretion secondary to high ADH levels and reduced effective arterial blood volume [1]. - While significant, it is a less frequent cause of hyponatremia compared to SIADH in the diverse hospitalized patient population. *Nephrotic syndrome* - **Nephrotic syndrome** can lead to hyponatremia, typically hypervolemic, as a result of profound hypoalbuminemia causing reduced plasma oncotic pressure and subsequent ADH release [1]. - It is a less common cause of hyponatremia compared to SIADH, which affects a broader range of hospitalized patients due to various underlying conditions [3].
Explanation: ***Administer fluids and medications*** - Central venous catheters (CVCs) are designed for the **long-term or rapid administration** of fluids, medications (especially **vasoactive drugs** or **chemotherapy**), and large volumes of nutrition (e.g., **total parenteral nutrition**) [1]. - Their placement in a large central vein allows for **rapid dilution** of infused substances, reducing the risk of peripheral vein irritation and damage [1]. *Monitor heart rate* - While a CVC itself doesn't directly monitor heart rate, an **ECG machine** connected to electrodes on the skin is used for this purpose. - Heart rate monitoring is a basic vital sign assessment, not a specialized function of a central venous catheter. *Deliver oxygen* - Oxygen is delivered via the respiratory system, typically through **nasal cannulas**, **face masks**, or **endotracheal tubes**. - A central venous catheter is part of the circulatory access system and plays no direct role in delivering oxygen for respiration. *Perform dialysis* - Specific types of central venous catheters, known as **dialysis catheters** or **permcaths**, are indeed used for hemodialysis, but this is a specialized application rather than the primary function of *any* central venous catheter [2]. - The primary, broad function of CVCs encompasses various therapeutic infusions, of which dialysis access is a distinct subset requiring a specific catheter design.
Explanation: ***Peripheral vein*** - For short-term (less than 14 days) **total parenteral nutrition (TPN)** without other central line indications, **peripheral access (PPN)** is often preferred due to lower risk and ease of insertion. - Peripheral veins are suitable for lower osmolarity solutions and pose fewer risks of **pneumothorax**, **hemothorax**, or **central line-associated bloodstream infections (CLABSIs)** compared to central lines. *Internal jugular vein* - This is a common site for **central venous access** and is used for long-term TPN or in critical care settings, not typically for short-term peripheral needs. - Insertion carries risks such as **pneumothorax**, **arterial puncture**, and **infection**, which are usually avoided if less invasive options suffice. *External jugular vein* - While easier to access than the internal jugular, it is still a **central venous access** site and is generally reserved for situations warranting central access. - It carries similar risks to other central lines, albeit slightly lower than the internal jugular for certain complications, but is not the first choice for short-term, low-risk TPN. *PICC line* - A **Peripherally Inserted Central Catheter (PICC) line** is used for **long-term intravenous access** (weeks to months) due to its placement in a central vein, making it unsuitable for a patient requiring TPN for less than 14 days. - While inserted peripherally, the tip resides in a central vein, carrying the risks associated with central access and requiring specialized insertion and care, making it an over-complication for short-term use.
Explanation: ***Blood pressure <90/60 mmHg*** - While hypotension can be a feature of **sepsis** or **septic shock**, it is **not** one of the specific diagnostic criteria for **Systemic Inflammatory Response Syndrome (SIRS)** itself. - SIRS criteria are focused on inflammatory responses like altered temperature, heart rate, respiratory rate, and white blood cell count, **before** the development of organ dysfunction or shock [1]. *WBC >12,000 or <4,000/mm³* - This is a **classic criterion for SIRS**, indicating an acute inflammatory response with either an elevated or depressed **white blood cell count** [1], [3]. - A differential count showing **>10% immature neutrophils (bands)** also meets this criterion, even if the total count is normal. *Temperature <36°C or >38°C* - This is a **key SIRS criterion**, reflecting the body's dysregulated thermoregulation in response to systemic inflammation [1]. - Both **fever (>38°C)** and **hypothermia (<36°C)** are indicative of SIRS [2]. *Heart rate >90/min* - **Tachycardia** is another specific and common **SIRS criterion**, indicating the body's physiological stress response to inflammation [1]. - An elevated **heart rate (HR)** is a compensatory mechanism to increase cardiac output during systemic stress.
Explanation: ***6 hours*** - **Transfusion-related acute lung injury (TRALI)** is defined as new acute lung injury occurring during or within **6 hours** after the completion of a blood transfusion [1]. - It is a severe and potentially life-threatening transfusion reaction characterized by **acute respiratory distress**, **hypoxemia**, and **bilateral pulmonary infiltrates** on chest imaging [1]. *48 hours* - While other transfusion reactions or complications may manifest within 48 hours, TRALI has a more **acute onset**, typically within the first 6 hours. - A pulmonary event occurring between 6 and 48 hours post-transfusion might be considered **delayed TRALI** or another diagnosis like **transfusion-associated circulatory overload (TACO)**, but the classic definition refers to the 6-hour window. *72 hours* - Reactions occurring 72 hours after transfusion are generally considered **delayed transfusion reactions**, which include conditions like **delayed hemolytic transfusion reactions** or **post-transfusion purpura**. - This timeframe is too long for the typical presentation of TRALI, which is characterized by rapid onset. *12 hours* - Although 12 hours falls within an acute window, the most commonly accepted and diagnostically crucial timeframe for TRALI is **within 6 hours** of transfusion. - A reaction occurring between 6 and 12 hours would still be considered suspiciously TRALI, but the strict definition emphasizes the earlier onset.
Explanation: ***Closed drainage technique to minimize bacterial entry*** - Maintaining a **closed drainage system** prevents the entry of bacteria into the urinary tract, which is a primary cause of CAUTIs. - This technique involves ensuring the connection between the catheter and the drainage bag remains sealed at all times, minimizing **environmental contamination**. *Prophylactic antibiotics are effective* - **Prophylactic antibiotics** are generally not recommended for routine CAUTI prevention due to concerns about **antibiotic resistance** and limited evidence of effectiveness [1]. - Their use is typically reserved for specific high-risk procedures or patient populations. *Use of face mask during catheter insertion* - While maintaining **asepsis** during catheter insertion is crucial, the use of a face mask specifically addresses **respiratory droplet transmission**, which is not the primary route of bacterial entry into the urinary system during catheterization. - **Sterile gloves** and a **sterile field** are more directly relevant for preventing contamination during insertion [1]. *Early catheter removal when clinically appropriate* - While **early catheter removal** is a critical strategy for CAUTI prevention by reducing dwell time, the question asks for the *primary* evidence-based intervention [1]. A **closed drainage system** directly addresses the mechanism of bacterial entry while the catheter is in place. - Reducing catheter duration minimizes risk, but the closed system ensures safety during the necessary period of catheterization.
Explanation: ***Liver function tests (LFTs)*** - **LFTs** are typically monitored periodically (e.g., weekly or bi-weekly) in patients on TPN, not daily, unless there are specific concerns about liver dysfunction [1]. - Daily monitoring is generally not required because changes in liver function due to TPN are usually insidious and not acutely life-threatening in hours. *Electrolyte* - **Electrolytes** (e.g., sodium, potassium, chloride) are crucial for cellular function and fluid balance [2]. They can fluctuate rapidly with TPN administration and patient's clinical status. - Daily measurement ensures prompt correction of imbalances to prevent serious complications like **cardiac arrhythmias** or neurological disturbances [2]. *Fluid intake and output* - **Fluid intake and output** are essential for assessing **hydration status** and preventing fluid overload or dehydration, which can change rapidly [2]. - Daily monitoring helps guide adjustments to fluid administration in TPN and other intravenous fluids. *Magnesium* - **Magnesium** is an important electrolyte involved in numerous enzymatic reactions and neuromuscular function, and its levels can be significantly affected by TPN [2]. - Daily or frequent monitoring is often necessary, especially in the initial phases of TPN or in patients with pre-existing deficiencies, to prevent complications such as **cardiac arrhythmias** or **weakness** [2].
Explanation: ***Hyperglycemia*** - Total parenteral nutrition (TPN) solutions contain a high concentration of **dextrose** (glucose), which can lead to elevated blood glucose levels, especially in patients with pre-existing metabolic issues or high infusion rates. - The sudden and continuous infusion of carbohydrates can overwhelm the body's **insulin response**, resulting in hyperglycemia [3]. *Hyperkalemia* - **Hypokalemia**, rather than hyperkalemia, is a more common electrolyte disturbance associated with TPN due to intracellular shifts of potassium with glucose metabolism [2]. - While TPN solutions do contain potassium, hyperkalemia is generally rare unless there is significant renal impairment or excessive potassium supplementation. *Hyperglycemia and Hyperkalemia* - While **hyperglycemia** is a common complication, **hyperkalemia** is not; in fact, hypokalemia is a more frequent concern linked to the significant glucose load in TPN. - This option incorrectly pairs a common complication with one that is rare and generally only seen in specific circumstances. *Hyperosmolar dehydration* - This condition, also known as **hyperosmolar hyperglycemic state (HHS)**, is a severe complication that can arise from uncontrolled hyperglycemia, where high glucose levels lead to osmotic diuresis and severe dehydration [1]. - While hyperglycemia is a precursor to hyperosmolar dehydration, the direct complication of TPN administration itself is the hyperglycemia.
Explanation: ***Post-operative atelectasis*** - **Type 3 respiratory failure**, also known as **perioperative respiratory failure**, is characterized by hypoxemia occurring typically after surgery. - **Atelectasis**, the collapse of lung tissue, is a common cause of hypoxemia in the post-operative period due to shallow breathing, pain, and anesthesia affecting lung volumes. *Kyphoscoliosis* - This condition leads to a **restrictive lung disease** due to chest wall deformity, causing chronic respiratory failure. [1] - It more typically results in **Type 2 respiratory failure** (hypercapnic) due to impaired ventilation over time. [1] *Flail chest* - Flail chest is a severe chest wall injury causing paradoxical movement, leading to **acute respiratory failure**. - It is often associated with **Type 1 (hypoxemic)** or **Type 2 (hypercapnic)** respiratory failure due to trauma-induced lung injury and impaired mechanics. *Pulmonary fibrosis* - This is a progressive interstitial lung disease causing **restrictive ventilatory defect** and impaired gas exchange. - It leads to chronic **Type 1 respiratory failure** (hypoxemic) as the lung tissue becomes stiff and scarred.
Explanation: ***Surgical intervention*** - **Fat embolism syndrome (FES)** is a medical emergency primarily managed with **supportive care**, not surgery. - Surgical intervention is only indicated for the **initial injury**, such as stabilizing long bone fractures, which helps prevent fat emboli, but not for treating an already established FES [1]. *Oxygen therapy* - **Oxygen therapy** is a crucial component of FES management, as the syndrome often leads to **hypoxemia** due to lung involvement. - It helps maintain adequate **tissue oxygenation** and can be administered via nasal cannula, face mask, or mechanical ventilation in severe cases. *Heparin administration* - **Heparin administration** was historically used with the rationale of preventing thrombus formation and potentially breaking down fat globules. - However, its effectiveness is **unproven**, and it carries risks such as bleeding, so it is generally **not recommended** for FES. *Low Molecular Weight Dextran* - **Low Molecular Weight Dextran** has been investigated for its potential to improve blood flow, reduce fat globule aggregation, and expand plasma volume in FES. - While some studies showed promising results, it is **not a universally accepted standard treatment** due to conflicting evidence and potential side effects.
Explanation: ***Both volume and pH of aspiration fluid influence severity.*** - The **severity** of aspiration pneumonia and pneumonitis is directly related to both the **volume** of aspirated material and its **pH** (acidity). - A larger volume and more acidic (lower pH) aspirate cause greater **lung injury** and inflammation. *Severity is influenced by the pH of aspiration fluid.* - While **pH** is a significant factor, it is not the sole determinant of severity. - Highly acidic aspirates (e.g., gastric acid) lead to severe chemical pneumonitis, but the **volume** also plays a critical role in the extent of lung damage. *Incidence increases during induction of anesthesia.* - The **risk** of aspiration is indeed higher during **induction of anesthesia** due to loss of protective airway reflexes. - However, this statement refers to the incidence of aspiration, not the **severity** of the resulting pneumonia. *Severity is influenced by the volume of aspiration.* - **Volume** is a crucial factor, with larger volumes causing more widespread and severe lung injury. - However, the **pH** of the aspirated material also significantly impacts the chemical damage to the bronchi and alveoli, making it an equally important determinant of severity.
Explanation: ***Burns*** - **Hypotonic solutions** are generally *not* indicated for burn patients because these patients typically lose large amounts of **isotonic fluid** through damaged skin. [1] - The primary goal in burn resuscitation is to replace lost plasma volume with **isotonic crystalloids** (e.g., Lactated Ringer's) to prevent **hypovolemic shock**. [1] *Hypernatremia* - **Hypernatremia** is a condition of excess sodium relative to water, meaning the body has a **water deficit**. [1] - **Hypotonic solutions** are used to gradually lower serum sodium by providing **free water** to dilute the excess sodium. *Free water deficit* - A **free water deficit** indicates a lack of pure water relative to solutes, leading to increased plasma osmolality. [2] - **Hypotonic solutions** are specifically designed to provide **free water** to correct this deficit and restore proper fluid balance. *Maintenance fluid therapy in stable patients* - For stable patients requiring maintenance fluids, **hypotonic solutions** (e.g., D5W with 0.45% NS) are often used to cover obligatory fluid losses and provide adequate water without causing **sodium overload**. [1] - In such cases, the goal is to prevent dehydration and electrolyte imbalances over time, which often requires a balance of electrolytes and **free water**. [1]
Explanation: **Sepsis** - **Catheter-related bloodstream infections (CRBSIs)** leading to sepsis are the most significant late complication [1]. This is due to the direct access the central line provides to the bloodstream, allowing pathogens to bypass the body's natural defenses [1]. - Sepsis can lead to **multi-organ dysfunction** and mortality, making it a critical concern for patients with central venous lines [2]. *Air embolism* - While a serious complication, an **air embolism** is typically an **early complication** associated with insertion or removal of the central line, or during tubing changes, rather than a late complication. - Proper technique and patient positioning can largely prevent air embolism. *Thromboembolism* - **Thromboembolism**, specifically central venous catheter-related thrombosis, can occur but is usually managed with anticoagulation and is often asymptomatic or causes localized swelling rather than immediately life-threatening systemic effects. - This is a less common and often less immediately life-threatening late complication compared to sepsis in terms of clinical significance. *Cardiac arrhythmias* - **Cardiac arrhythmias** are usually an **early complication** during insertion if the guidewire or catheter tip irritates the heart muscle. - Once the catheter is properly placed and secured, the risk of ongoing arrhythmias directly caused by the catheter becomes significantly low.
Explanation: ***Systolic BP less than 90 mm/Hg*** - A **systolic blood pressure below 90 mm/Hg** indicates **hypotension**, reflecting inadequate tissue perfusion and potential **shock**, which is a critical sign of severity in any acute illness [1]. - This suggests **cardiovascular compromise** and requires immediate medical attention to prevent organ damage [1]. *Temp more than 38.5°C* - A **fever above 38.5°C** (101.3°F) indicates an infection or inflammatory process but is not as immediate a sign of life-threatening severity as profound hypotension. - While concerning, fever alone rarely signals imminent circulatory collapse in individuals without underlying conditions. *No significant clinical sign* - This option is incorrect because **systolic blood pressure less than 90 mm/Hg** is a highly significant clinical sign of severity, indicating potential decompensation. - Relying on the absence of signs can lead to delays in critical care for patients exhibiting clear signs of distress [1]. *Heart rate more than 100 bpm* - A **heart rate greater than 100 bpm** (**tachycardia**) can be a response to various stressors, including fever, pain, or anxiety, and is less specific for severe circulatory compromise than hypotension [1]. - While it may indicate an underlying problem, it is often a compensatory mechanism that does not, on its own, signify immediate danger without other signs of organ dysfunction.
Explanation: ***Signs and symptoms usually subside within 2-3 weeks of onset*** - TRALI is characterized by **acute onset**, typically within 6 hours of transfusion, and symptoms often resolve within **48-96 hours**. - A resolution period of **2-3 weeks** is significantly longer than the typical course for TRALI, suggesting a different underlying process. *Supportive care is the mainstay of treatment* - **Supportive care**, including oxygen therapy and mechanical ventilation if needed, is indeed the primary treatment for TRALI. - There is no specific antidote or targeted therapy for TRALI, making symptomatic management crucial. *Steroids have a doubtful role in management* - The use of **corticosteroids** in TRALI management is **controversial** and generally not recommended. - Current evidence does not support their routine use, and they are typically reserved for specific situations or not used at all. *Mortality is less than 10%* - While TRALI is a serious complication, its **mortality rate has significantly decreased** over the years due to improved recognition and mitigation strategies, now typically ranging from 5-10%. - This statement is generally considered true in contemporary medical practice.
Explanation: normal saline 0.9% is most suitable to treat acute severe hyponatremia - While 0.9% normal saline can be used in some hyponatremia cases, **acute severe hyponatremia** (especially with neurological symptoms) typically requires **hypertonic saline (3%)** to rapidly increase serum sodium and prevent cerebral edema. [2] - Normal saline contains 154 mEq/L of sodium, which is often insufficient to correct severe hyponatremia quickly enough [1]. *fluid of choice for head injury patient* - **Normal saline (0.9%) is often *not* the fluid of choice for head injuries**; rather, **hypertonic saline** is often preferred as it can decrease intracranial pressure (ICP) by drawing water out of brain cells. - Isotonic fluids like normal saline can contribute to cerebral edema if given in large quantities, though it's still safer than hypotonic fluids. *fluid of choice for hypovolemic shock* - **Normal saline (0.9%) is generally considered the fluid of choice for initial resuscitation in hypovolemic shock** as it is an isotonic crystalloid that effectively expands intravascular volume [1]. - It readily distributes across the extracellular fluid compartment, restoring circulating blood volume. *lead to hyperchloremic metabolic acidosis* - **Normal saline (0.9%) contains a higher concentration of chloride (154 mEq/L) than plasma (98-106 mEq/L)**, and when infused in large volumes, it can lead to **hyperchloremia** [1]. - This excess chloride can shift the bicarbonate buffer system, resulting in a **non-anion gap (hyperchloremic) metabolic acidosis**.
Explanation: ***Granulomatosis with polyangiitis (GPA)*** - **Granulomatosis with polyangiitis (GPA)**, previously known as Wegener's granulomatosis, classically presents with a **triad of upper airway disease**, **lower airway disease**, and **glomerulonephritis** [1]. - **Cavitating lung lesions** are a hallmark feature of GPA due to the necrotizing vasculitis and granuloma formation in the pulmonary parenchyma [1]. *Polyarteritis nodosa (PAN)* - **Polyarteritis nodosa** is a necrotizing vasculitis of **medium-sized arteries**, but it typically **spares the pulmonary circulation** [1]. - Its clinical manifestations usually involve the skin, peripheral nerves, kidneys, and gastrointestinal tract, with **pulmonary involvement being rare**. *Systemic lupus erythematosus (SLE)* - **Systemic lupus erythematosus** can affect the lungs, causing pleurisy, pneumonitis, or interstitial lung disease, but **cavitating lesions are highly unusual** [1]. - **Pulmonary hemorrhage** or **thromboembolism** can occur, but these do not typically lead to cavitation [1]. *Goodpasture's syndrome* - **Goodpasture's syndrome** is characterized by rapidly progressive **glomerulonephritis** and **pulmonary hemorrhage** due to anti-GBM antibodies [1]. - While it causes lung disease, it typically manifests as **diffuse alveolar hemorrhage** rather than cavitating lesions [1].
Explanation: **Sepsis** - **Catheter-related bloodstream infections (CRBSIs)** are the most common late complication of central venous lines, leading to sepsis [1]. - The risk of sepsis increases with the **duration** of catheter placement, frequency of line access, and inadequate aseptic technique [1]. *Air embolism* - An **air embolism** is typically an immediate or early complication during insertion or removal of the central line, or connection/disconnection of administration sets. - It is not considered a late complication as it occurs due to a sudden entry of air into the venous system. *Thromboembolism* - While **thrombosis** can complicate central venous lines, leading to potential thromboembolism, it is less common than sepsis as a late complication [2]. - The formation of a thrombus is often localized to the catheter tip or vessel wall and may or may not lead to a symptomatic embolism [2]. *Cardiac arrhythmias* - **Cardiac arrhythmias** can occur during central venous line insertion if the guidewire or catheter tip irritates the myocardium, making it an immediate or early complication. - This is usually a transient event and not a long-term or late complication associated with the mere presence of the catheter.
Explanation: ***T.R.A.L.I*** - **Transfusion-Related Acute Lung Injury (TRALI)** is the leading cause of transfusion-related mortality, characterized by sudden onset of **non-cardiogenic pulmonary edema** within 6 hours of transfusion [1]. - It is thought to be mediated by **donor antibodies** that activate recipient neutrophils in the pulmonary vasculature, leading to capillary leakage [1]. *Hyperkalemia* - Can occur, especially in massive transfusions or rapid infusion of stored blood, but it is less common and typically less lethal than TRALI [1]. - Often manageable with interventions to shift potassium intracellularly or remove it from the body. *Citrate toxicity* - Associated with **massive transfusions** or in patients with **liver dysfunction**, as the liver metabolizes citrate. - Leads to **hypocalcemia** due to citrate chelating calcium, but is rarely fatal and reversible with calcium administration. *Hypothermia* - Can occur with rapid infusion of large volumes of cold blood products, particularly in trauma or surgical settings. - While it can exacerbate coagulopathy and arrhythmias, it is generally preventable with blood warmers and rarely a direct cause of death compared to TRALI.
Explanation: Flexion of wrist - **Flexion of the wrist** compresses the radial artery and surrounding structures, making it difficult to locate and successfully access the artery for ABG sampling. - To facilitate arterial puncture, the wrist should be **slightly extended** to make the radial artery more prominent and easier to palpate and access. *Allen's test* - The **Allen's test** is a crucial step performed prior to radial artery puncture to assess the patency of the ulnar artery and ensure adequate collateral circulation to the hand. - If the ulnar artery is not patent, radial artery puncture could lead to **ischemia** of the hand. *Heparin to rinse the syringe* - **Heparin** is used to rinse the syringe to prevent the blood sample from clotting, which would render the ABG analysis inaccurate. - A small amount of **anticoagulant** ensures the blood remains liquid until it reaches the analyzer. *Poking at 45deg angle* - An insertion angle of **45 degrees** (or 30-45 degrees) is the standard technique for obtaining an ABG sample from the radial artery. - This angle allows for optimal access to the artery while minimizing the risk of puncturing through both vessel walls or causing hematoma formation.
Hospital Systems and Quality Improvement
Practice Questions
Inpatient Management of Common Conditions
Practice Questions
Hospital-Acquired Complications
Practice Questions
Nosocomial Infections
Practice Questions
Inpatient Diabetes Management
Practice Questions
VTE Prophylaxis and Management
Practice Questions
Delirium Prevention and Management
Practice Questions
Safe Transitions of Care
Practice Questions
Medication Reconciliation
Practice Questions
Inpatient Procedures
Practice Questions
Rapid Response and Code Management
Practice Questions
Resource Utilization and Length of Stay
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free